Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Dec;65(12):4965–4971. doi: 10.1128/iai.65.12.4965-4971.1997

Expression of the superantigen Mycoplasma arthritidis mitogen in Escherichia coli and characterization of the recombinant protein.

K L Knudtson 1, M Manohar 1, D E Joyner 1, E A Ahmed 1, B C Cole 1
PMCID: PMC175716  PMID: 9393783

Abstract

Mycoplasma arthritidis mitogen (MAM), is a soluble protein with classical superantigenic properties and is produced by an organism that causes an acute and chronic proliferative arthritis. Unfortunately, the process of obtaining purified MAM from M. arthritidis culture supernatants is extremely time-consuming and costly, and very little material is recovered. Thus, our laboratory has expressed MAM in Escherichia coli by using a protein fusion expression system. The construction and expression of recombinant MAM (rMAM), as well as a comparison of the biological properties of rMAM to those of native MAM, are discussed. Briefly, conversion of the three UGA codons to UGG codons was required to obtain full-length expression and mitogenic activity of rMAM. Antisera to native MAM recognized both rMAM and the fusion protein. The T-cell receptor Vbeta and major histocompatibility complex class II receptor usages by rMAM and the fusion protein were identical to that of native MAM. In addition, the ability to induce suppression and form the superantigen bridge could also be demonstrated with rMAM. Importantly, dose-response experiments indicated that homogeneous native MAM and rMAM were of equal potency. Thus, MAM has been successfully expressed in E. coli, thereby creating a viable alternative to native MAM.

Full Text

The Full Text of this article is available as a PDF (375.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkin C. L., Cole B. C., Sullivan G. J., Washburn L. R., Wiley B. B. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V. A small basic protein from culture supernatants is a potent T cell mitogen. J Immunol. 1986 Sep 1;137(5):1581–1589. [PubMed] [Google Scholar]
  2. Atkin C. L., Wei S., Cole B. C. The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide. Infect Immun. 1994 Dec;62(12):5367–5375. doi: 10.1128/iai.62.12.5367-5375.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baccala R., Smith L. R., Vestberg M., Peterson P. A., Cole B. C., Theofilopoulos A. N. Mycoplasma arthritidis mitogen. V beta engaged in mice, rats, and humans, and requirement of HLA-DR alpha for presentation. Arthritis Rheum. 1992 Apr;35(4):434–442. doi: 10.1002/art.1780350413. [DOI] [PubMed] [Google Scholar]
  4. Cole B. C., Atkin C. L. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol Today. 1991 Aug;12(8):271–276. doi: 10.1016/0167-5699(91)90125-D. [DOI] [PubMed] [Google Scholar]
  5. Cole B. C., Balderas R. A., Ahmed E. A., Kono D., Theofilopoulos A. N. Genomic composition and allelic polymorphisms influence V beta usage by the Mycoplasma arthritidis superantigen. J Immunol. 1993 Apr 15;150(8 Pt 1):3291–3299. [PubMed] [Google Scholar]
  6. Cole B. C., David C. S., Lynch D. H., Kartchner D. R. The use of transfected fibroblasts and transgenic mice establishes that stimulation of T cells by the Mycoplasma arthritidis mitogen is mediated by E alpha. J Immunol. 1990 Jan 15;144(2):420–424. [PubMed] [Google Scholar]
  7. Cole B. C., Daynes R. A., Ward J. R. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. I. Transformation is associated with an H-2-linked gene that maps to the I-E/I-C subregion. J Immunol. 1981 Nov;127(5):1931–1936. [PubMed] [Google Scholar]
  8. Cole B. C., Kartchner D. R., Wells D. J. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis (MAM). VIII. Selective activation of T cells expressing distinct V beta T cell receptors from various strains of mice by the "superantigen" MAM. J Immunol. 1990 Jan 15;144(2):425–431. [PubMed] [Google Scholar]
  9. Cole B. C., Kartchner D. R., Wells D. J. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. VII. Responsiveness is associated with expression of a product(s) of the V beta 8 gene family present on the T cell receptor alpha/beta for antigen. J Immunol. 1989 Jun 15;142(12):4131–4137. [PubMed] [Google Scholar]
  10. Cole B. C., Knudtson K. L., Oliphant A., Sawitzke A. D., Pole A., Manohar M., Benson L. S., Ahmed E., Atkin C. L. The sequence of the Mycoplasma arthritidis superantigen, MAM: identification of functional domains and comparison with microbial superantigens and plant lectin mitogens. J Exp Med. 1996 Mar 1;183(3):1105–1110. doi: 10.1084/jem.183.3.1105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cole B. C. The immunobiology of Mycoplasma arthritidis and its superantigen MAM. Curr Top Microbiol Immunol. 1991;174:107–119. doi: 10.1007/978-3-642-50998-8_8. [DOI] [PubMed] [Google Scholar]
  12. Cole B. C., Wells D. J. Immunosuppressive properties of the Mycoplasma arthritidis T-cell mitogen in vivo: inhibition of proliferative responses to T-cell mitogens. Infect Immun. 1990 Jan;58(1):228–236. doi: 10.1128/iai.58.1.228-236.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Crow M. K., Zagon G., Chu Z., Ravina B., Tumang J. R., Cole B. C., Friedman S. M. Human B cell differentiation induced by microbial superantigens: unselected peripheral blood lymphocytes secrete polyclonal immunoglobulin in response to Mycoplasma arthritidis mitogen. Autoimmunity. 1992;14(1):23–32. doi: 10.3109/08916939309077353. [DOI] [PubMed] [Google Scholar]
  14. Friedman S. M., Posnett D. N., Tumang J. R., Cole B. C., Crow M. K. A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis Rheum. 1991 Apr;34(4):468–480. doi: 10.1002/art.1780340412. [DOI] [PubMed] [Google Scholar]
  15. Herman A., Kappler J. W., Marrack P., Pullen A. M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol. 1991;9:745–772. doi: 10.1146/annurev.iy.09.040191.003525. [DOI] [PubMed] [Google Scholar]
  16. Ho S. N., Hunt H. D., Horton R. M., Pullen J. K., Pease L. R. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989 Apr 15;77(1):51–59. doi: 10.1016/0378-1119(89)90358-2. [DOI] [PubMed] [Google Scholar]
  17. Irwin M. J., Hudson K. R., Ames K. T., Fraser J. D., Gascoigne N. R. T-cell receptor beta-chain binding to enterotoxin superantigens. Immunol Rev. 1993 Feb;131:61–78. doi: 10.1111/j.1600-065x.1993.tb01530.x. [DOI] [PubMed] [Google Scholar]
  18. Kirchner H., Brehm G., Nicklas W., Beck R., Herbst F. Biochemical characterization of the T-cell mitogen derived from Mycoplasma arthritidis. Scand J Immunol. 1986 Sep;24(3):245–249. doi: 10.1111/j.1365-3083.1986.tb02091.x. [DOI] [PubMed] [Google Scholar]
  19. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  20. Lee C., Levin A., Branton D. Copper staining: a five-minute protein stain for sodium dodecyl sulfate-polyacrylamide gels. Anal Biochem. 1987 Nov 1;166(2):308–312. doi: 10.1016/0003-2697(87)90579-3. [DOI] [PubMed] [Google Scholar]
  21. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sawada T., Pergolizzi R., Ito K., Silver J., Atkin C., Cole B. C., Chang M. D. Replacement of the DR alpha chain with the E alpha chain enhances presentation of Mycoplasma arthritidis superantigen by the human class II DR molecule. Infect Immun. 1995 Sep;63(9):3367–3372. doi: 10.1128/iai.63.9.3367-3372.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tumang J. R., Cherniack E. P., Gietl D. M., Cole B. C., Russo C., Crow M. K., Friedman S. M. T helper cell-dependent, microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses. J Immunol. 1991 Jul 15;147(2):432–438. [PubMed] [Google Scholar]
  24. Tumang J. R., Posnett D. N., Cole B. C., Crow M. K., Friedman S. M. Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. J Exp Med. 1990 Jun 1;171(6):2153–2158. doi: 10.1084/jem.171.6.2153. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES